Brief: Rubric Capital Management Reports 12.82% Stake In Mereo Biopharma Group
27/05/2022 24:38
May 26 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* RUBRIC CAPITAL MANAGEMENT LP REPORTS 12.82% STAKE IN MEREO
BIOPHARMA GROUP AS OF MAY 26, 2022 - SEC FILING
* RUBRIC CAPITAL MANAGEMENT LP ACQUIRED MEREO BIOPHARMA ADRS
THAT
REPRESENT ORDINARY SHARES BECAUSE THEY BELIEVED ADRS WERE
UNDERVALUED
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand